New drug trial aims to boost Infection-Fighting cells in chronic blood disorder
Disease control
Recruiting now
This study is testing whether an investigational drug called mavorixafor can help people with chronic neutropenia, a condition where the body has too few infection-fighting white blood cells. Participants will take mavorixafor or a placebo while continuing their usual treatments,…
Phase: PHASE3 • Sponsor: X4 Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC